Skip to main content

Acute Myelogenous Leukemias

  • Chapter
Modern Hematology

Part of the book series: Contemporary Hematology ((CH))

  • 139 Accesses

Abstract

Acute myelogenous leukemias (AML) are aggressive hematologic neoplasms that requires urgent treatment. Despite intensive treatment with cytostatic drugs, only a minority of patients can be cured at present. In adults, about 80% of all acute leukemias belong to the group of AML. The term “acute nonlymphocytic leukemia” is often used in an identical fashion for AML. The incidence of AML is about two to four new cases/100,000 persons. AML is rare in children and young adults; the incidence of AML increases with advancing age, the age median being around 60–70 yr.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  • Bloomfield CD, Lawrence D, Byrd JC, et al. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res 1998; 58: 4173–4179.

    PubMed  CAS  Google Scholar 

  • Burnett AK, Eden OB. The treatment of acute leukaemia. Lancet 1997; 349: 270–275.

    Article  PubMed  CAS  Google Scholar 

  • Burnett AK, Goldstone AH, Stevens RMF, et al. Randomised comparison of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of the MRC AML10 trial. Lancet 1998; 351: 700–708.

    Article  PubMed  CAS  Google Scholar 

  • Caligiuri MA, Strout MP, Gilliland DG. Molecular biology of acute myeloid leukemia. Semin Oncol 1997; 24: 32–44.

    PubMed  CAS  Google Scholar 

  • Cassileth PA, Harrington DP, Appelbaum FR, et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in remission. N Engl J Med 1998; 339: 1649–1656.

    Article  PubMed  CAS  Google Scholar 

  • Fenaux P, Chomienne C, Degos L. Acute promyelocytic leukemia: biology and treatment. Semin Oncol 1997; 24: 92–102.

    PubMed  CAS  Google Scholar 

  • Mayer RJ, Davis RB, Schiffer CA, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 1994; 331: 896–903.

    Article  PubMed  CAS  Google Scholar 

  • Tallman MS, Andersen JW, Schiffer CA, et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997; 337: 1021–1028.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Munker, R., Hiller, E., Paquette, R. (2000). Acute Myelogenous Leukemias. In: Modern Hematology. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-203-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-203-6_9

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5873-3

  • Online ISBN: 978-1-59259-203-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics